0000000000470946

AUTHOR

Krummenauer F

showing 2 related works from this author

Clinical Outcome and Subjective Quality of Life after Photodynamic Therapy in Patients with Age-Related Macular Degeneration

2005

PURPOSE. Whereas the efficacy of photodynamic therapy (PDT) in preventing the progression of age-related macular degeneration (ARMD) is established, its effect on quality of life is under discussion. METHODS. All patientswho underwent PDT during 2000 and 2001 at the University Eye Hospital of Mainz were interviewed using a standardized 82-item questionnaire on quality of life and patient satisfaction in ophthalmologic patients. Information was assessed in terms of 82 questions; global scores ranging from 1.0 (optimum self-estimated quality of life) to 4.0 (worst) were derived. Cataract patients' scores were used to characterize the ARMD patients' subjective outcome; the latter were then rel…

Malemedicine.medical_specialtyPorphyrinsVisual acuitymedicine.medical_treatmentVisual AcuityPsychological interventionPhotodynamic therapyLogistic regressionMacular Degeneration03 medical and health sciences0302 clinical medicinePatient satisfactionQuality of lifeSurveys and QuestionnairesInternal medicineActivities of Daily LivingmedicineHumansIn patientAgedRetrospective StudiesAged 80 and overPhotosensitizing Agentsbusiness.industryVerteporfinGeneral MedicineMacular degenerationmedicine.diseaseChoroidal Neovascularizationeye diseasesOphthalmologyCross-Sectional StudiesTreatment OutcomePhotochemotherapyPatient SatisfactionQuality of Life030221 ophthalmology & optometryPhysical therapyFemalemedicine.symptombusiness030217 neurology & neurosurgeryEuropean Journal of Ophthalmology
researchProduct

Contrast sensitivity and glare disability by halogen light after monofocal and multifocal lens implantation

2000

BACKGROUND—Standard examination of contrast sensitivity under conditions of glare disability is performed with incandescent light. A new halogen glare test that simulates glare as seen with oncoming vehicle headlights was used to measure glare disability in patients implanted with multifocal and monofocal intraocular lenses (IOLs). METHODS—28 patients with an average age of 69 years (SD 12 years) were implanted with a monofocal IOL (SI-40NB, Allergan) and 28 patients with an average of 66 years (12 years) were implanted with a refractive multifocal IOL (Array-SA-40N, Allergan). All patients were followed for 5 months postoperatively. Contrast sensitivity at four spatial frequencies (3, 6, 1…

AdultMaleAgingAutomobile Drivingmedicine.medical_specialtygenetic structuresEye diseasemedicine.medical_treatmentmedia_common.quotation_subjecteducationPoison controlIntraocular lensAstigmatismGlareContrast SensitivityVision disorderCellular and Molecular NeuroscienceHalogensOphthalmologymedicineHumansContrast (vision)Postoperative PeriodDioptreAgedmedia_commonAged 80 and overLenses Intraocularbusiness.industryGlare (vision)Middle AgedOriginal articles - Clinical sciencemedicine.diseaseeye diseasesSensory SystemsSurgeryOphthalmologyFemalesense organsmedicine.symptombusinessFollow-Up StudiesBritish Journal of Ophthalmology
researchProduct